Bruker aligns with U of Zurich on microbial identification
The Institute of Medical Microbiology (IMM) at the University of Zurich is using Bruker’s Maldi Biotyper system as its new microbial identification system. The IMM and Bruker will work in collaboration to focus on coryneform bacteria, actinomycetes, fastidious gram negative bacteria and moulds.
The IMM has developed its own algorithms and workflows for identification and antibiotics susceptibility testing. Those approaches are mainly based on Kirby-Bauer testing methods, according to the Billerica, Mass.-based company, which are now applied in combination with Maldi-TOF based indentification technology.
“During our daily routine we increasingly face the problem of a broadening spectrum of infections and of complex resistance patterns," said Michael Hombach, PhD, associate head of bacteriology at the IMM.
The IMM has developed its own algorithms and workflows for identification and antibiotics susceptibility testing. Those approaches are mainly based on Kirby-Bauer testing methods, according to the Billerica, Mass.-based company, which are now applied in combination with Maldi-TOF based indentification technology.
“During our daily routine we increasingly face the problem of a broadening spectrum of infections and of complex resistance patterns," said Michael Hombach, PhD, associate head of bacteriology at the IMM.